1. A. Durukan and T. Tatlisumak, “Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection,” Exp. Transl. Stroke Med., 2, No. 2 (2010).doi: https://doi.org/10.1186/2040-7378-2-2 .
2. A. Shaldubina, G. Agam, and R. H. Belmaker, “The mechanism of lithium action: state of the art, ten years later,” Prog. Neuropsychopharmacol. Biol. Psychiat., 25, No. 4, 855–866 (2001).
3. P. He, Y. Y. Fan, L. Y. Zhang, et al., “Effect of endogenous histamine on ischemic preconditioning induced cerebral ischemic tolerance,” Zhejiang Da Xue Xue Bao Yi Xue Ban, 38, No. 6, 579–583 (2009).
4. N. S. Thaddeus, “Animal models of global cerebral ischemia,” in Acute Stroke, Bench to Bedside, A. Bhardwaj, et al. (eds.), Informa Healthcare, New York (2006), pp. 275–292.
5. V. Borlongan, T. K. Koutouzis, T. S. Randall, et al., “Systemic 3-nitropropionic acid: Behavioral deficits and striatal damage in adult rats,” Brain Res. Bull., 36, No. 6, 549–556 (1995).